Clinical Trials Directory

Trials / Completed

CompletedNCT00953836

Plasma Pharmacokinetics of Alkylresorcinol Metabolites; New Candidate Biomarkers for Whole Grain Rye and Wheat Intake

Kinetic Study of Two Known Alkylresorcinol Metabolites in Human Subjects After the Intake of Rye Fiber, the Most Abundant Source of Alkylresorcinols in Diet.

Status
Completed
Phase
Study type
Observational
Enrollment
15 (actual)
Sponsor
University of Helsinki · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate the kinetics of two known alkylresorcinol metabolites in human subjects after intake of high-fiber rye bread. Whole grain rye is the most abundant source of alkylresorcinols.

Conditions

Timeline

Start date
2009-03-01
Primary completion
2009-04-01
Completion
2009-05-01
First posted
2009-08-06
Last updated
2009-08-06

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT00953836. Inclusion in this directory is not an endorsement.